Mabion, NovalGen Partner to Bring NVG-222 to Market
30 Jun 2025 //
CONTRACTPHARMA
NovalGen announces one oral and one poster presentation at Annual Meeting
02 Nov 2023 //
GLOBENEWSWIRE
NovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors
09 Jan 2023 //
GLOBENEWSWIRE
NovalGen announces one oral and two poster presentations at the ASHAM
03 Nov 2022 //
GLOBENEWSWIRE
NovalGen announces compelling data from the PI/II Study of NVG-111
26 May 2022 //
GLOBENEWSWIRE